Leveraging AI & Digital Pathology to Advance Biomarker Diagnostics in Clinical Trials & Routine Practice
Time: 2:10 pm
day: Day 2 - Track B (2)
Details:
- How AI-driven diagnostics can deliver transformative value to patients and pharma by improving patient identification in clinical routine and clinical trials
- Case study: Accelerating gBRCA genetic testing for high-risk patients with BRACAnalysis– Key learnings and progress
- Strategies to increase digital pathology adoption
